Statistical analysis of the correlation between HOXA11 expression and clinico-pathological characteristics and revealed that higher HOXA11 expression is associated with advanced AJCC stage (P<0.0001 & P<0.0001), advanced T phase of tumor (P<0.0001 & P<0.0001), advanced lymph node metastasis (P<0.0001 & P<0.0001) and larger tumor volume (P=0.024 & P=0.006) in training cohort and validation ones respectively (Table S2-3). The gene discussed is HOXA11; the disease is neoplasm.